According to Theravance Biopharma 's latest financial reports the company's total assets are $0.38 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $0.38 B | -37.11% |
2022-12-31 | $0.60 B | 62.05% |
2021-12-31 | $0.37 B | -20.09% |
2020-12-31 | $0.46 B | 14.73% |
2019-12-31 | $0.40 B | -27.03% |
2018-12-31 | $0.56 B | 26.92% |
2017-12-31 | $0.44 B | -30.95% |
2016-12-31 | $0.63 B | 113% |
2015-12-31 | $0.30 B | -11.15% |
2014-12-31 | $0.33 B | 1241.59% |
2013-12-31 | $25.17 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Corcept Therapeutics
CORT | $0.62 B | 62.70% | ๐บ๐ธ USA |
Collegium Pharmaceutical
COLL | $1.14 B | 199.30% | ๐บ๐ธ USA |
Catalyst Pharmaceuticals CPRX | $0.47 B | 23.07% | ๐บ๐ธ USA |
Catalent CTLT | $9.98 B | 2,514.67% | ๐บ๐ธ USA |